Form 4: Entrada Therapeutics Director Peter S. Kim Acquires 25,000 Shares

Director Peter S. Kim of Entrada Therapeutics, Inc. purchased 25,000 shares of common stock at an average price of $14.5869 on May 14, 2024.

Summary

• On May 14, 2024, Peter S. Kim, a director of Entrada Therapeutics, Inc., acquired 25,000 shares of the company's common stock.
• The shares were purchased at a weighted average price of $14.5869.
• The price range for individual transactions was between $14.465 and $14.73.
• Following the transaction, Kim directly owns 92,412 shares of Entrada Therapeutics.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's financial health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's prospects. Purchases by directors are often viewed positively.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates